In the current study, we found that SNPs in hepcidin regulatory BMP/Smad4/Hamp pathway were significantly associated with disease outcomes after definitive radiotherapy in NSCLC; Hamp rs1882694 in particular was associated with all of the studied endpoints in both univariate and multivariate analyses. This evidence concerns the gene SMAD4 and non-small cell lung carcinoma.